Description
A new Transnasal Lacrimal Stent has been introduced by FCI Ophthalmics, Inc. Designed by Bruce B. Becker, M.D., the Transnasal Lacrimal Stent addressed the limitations previously encountered with balloon catheter DCR and other forms of endoscopic DCR. Brought in to position through the nose, it has a relatively large diameter. Because there is no need to pass the very large diameter end of the stent through the canaliculus, the stent can have a much larger diameter than a tube placed in the traditional fashion.
- Transnasal Lacrimal Stent
- FCI Ophthalmics Inc.
- Get quote
- Larger stent results in an ostium of larger diameter thus boosting the success rate of balloon catheter or endoscopic DCR.
- Unlike in an external DCR, The Transnasal Lacrimal Stent requires no external incision.
- It leaves no cutaneous scars and results in a quicker recovery time.
- US FDA
- Inquire